Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.84
-0.35 (-5.65%)
At close: Mar 12, 2026, 4:00 PM EDT
5.91
+0.07 (1.20%)
After-hours: Mar 12, 2026, 4:48 PM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $512.96 million as of March 12, 2026. Its market cap has increased by 111.44% in one year.
Market Cap
512.96M
Enterprise Value
410.51M
1-Year Change
111.44%
Ranking
Category
Stock Price
$5.84
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $512.96M, an increase of 140.49%. That is a compound annual growth rate of 6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 543.70M | 5.47% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
| Jan 27, 2012 | 213.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 573.54M |
| Contineum Therapeutics | 559.29M |
| Immix Biopharma | 551.20M |
| Vanda Pharmaceuticals | 549.11M |
| YD Bio | 541.81M |
| Rocket Pharmaceuticals | 538.50M |
| Invivyd | 536.93M |
| Lyell Immunopharma | 534.07M |